WALTHAM, Mass.—Fresenius Medical Care AG & Co. KGaA announced May 25 that it signed a sales and purchase agreement with Bumrungrad International Ltd. to acquire Asia Renal Care Ltd.
The acquisition marks an expansion of the company’s activities in the field of dialysis services in the Asia-Pacific region. Financial details of the agreement were not disclosed.
The transaction will be subject to antitrust notification in Taiwan and Singapore. If approved and closed, the acquired operations will add approximately $80 million in annual revenue and be accretive to earnings in the first year after closing of the transaction, according to Fresenius.
Founded in 1997, Asia Renal Care has since become the second largest provider of dialysis and related services in the Asia-Pacific region (behind Fresenius Medical Care). Asia Renal Care operates more than 100 clinics throughout Asia treating about 6,200 patients.
In 2007, Asia Renal Care became a wholly owned subsidiary of Bumrungrad International Ltd., an associate company of Bumrungrad Hospital PCL.
We are very pleased to further strengthen our activities and presence in dialysis services across most of the key Asian countries. Through this strategic and significant acquisition, we add to our existing leading position a large business managed by excellent professionals and very valuable partners in every single market.” said Roberto Fusté, Member of the Management Board and CEO for Asia-Pacific.
